推荐产品
品質等級
化驗
≥98.0% (TLC)
形狀
crystalline
顏色
white
溶解度
water: 49.00-51.00 mg/mL, clear, colorless
SMILES 字串
OCC1OCC(O)C(O)C1O
InChI
1S/C6H12O5/c7-1-4-6(10)5(9)3(8)2-11-4/h3-10H,1-2H2
InChI 密鑰
MPCAJMNYNOGXPB-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
相关类别
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
Masaya Sakamoto et al.
Cardiovascular diabetology, 11, 92-92 (2012-08-08)
No previous studies have compared the DPP-4 inhibitors vildagliptin and sitagliptin in terms of blood glucose levels using continuous glucose monitoring (CGM) and cardiovascular parameters. Twenty patients with type 2 diabetes mellitus were randomly allocated to groups who received vildagliptin
Andrzej S Januszewski et al.
Diabetes research and clinical practice, 95(1), e17-e19 (2011-10-26)
An assay of plasma 1,5-anhydroglucitol was evaluated. Assay CVs, effects of four plasma freeze-thaw cycles, glucose up to 80 mmol/L and triglycerides up to 20 mmol/L were acceptable. 1,5-anhydroglucitol levels were significantly lower in diabetic vs. non-diabetic subjects and correlated
Sanjeev N Mehta et al.
Pediatric diabetes, 13(3), 278-284 (2011-11-09)
Serum 1,5-anhydroglucitol (1,5-AG) is a marker of hyperglycemic excursions in adults with diabetes and hemoglobin A1c (HbA1c) < 8%. We compared 1,5-AG levels among youth and young adults with and without type 1 diabetes (T1D) and investigated the utility of
Stephen P Juraschek et al.
Diabetes care, 35(11), 2265-2270 (2012-08-10)
Fructosamine, glycated albumin, and 1,5-anhydroglucitol (1,5-AG) are of interest for monitoring short-term glycemic control in patients with diabetes; however, their associations with diabetes risk are uncharacterized. We used Cox proportional hazards models to examine the associations of fructosamine, glycated albumin
David C Klonoff et al.
Diabetes, obesity & metabolism (2018-12-12)
To evaluate the efficacy and safety of fast-acting insulin aspart (faster aspart) vs insulin aspart (IAsp) used in continuous subcutaneous insulin infusion (CSII) in participants with type 1 diabetes (T1D). This was a double-blind, treat-to-target, randomized, 16-week trial investigating CSII
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门